Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
959
-
Total 13F shares, excl. options
-
88,855,592
-
Shares change
-
-698,829
-
Total reported value, excl. options
-
$49,577,081,270
-
Value change
-
-$361,559,165
-
Put/Call ratio
-
1.27%
-
Number of buys
-
501
-
Number of sells
-
-385
-
Price
-
$558.54
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2021
1,095 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2021.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 959 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88,855,592 shares
of 104,986,330 outstanding shares and own 84.64% of the company stock.
Largest 10 shareholders include FMR LLC (10,910,694 shares), BlackRock Inc. (9,033,549 shares), VANGUARD GROUP INC (7,969,660 shares), Capital World Investors (5,307,957 shares), STATE STREET CORP (4,516,716 shares), WELLINGTON MANAGEMENT GROUP LLP (4,057,382 shares), JPMORGAN CHASE & CO (3,788,393 shares), LOOMIS SAYLES & CO L P (2,754,224 shares), GEODE CAPITAL MANAGEMENT, LLC (1,708,000 shares), and HARRIS ASSOCIATES L P (1,445,053 shares).
This table shows the top 959 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.